Valuation: Amneal Pharmaceuticals, Inc.

Market Cap 6B 5.2B 4.91B 4.45B 8.35B 575B 8.41B 58.62B 22.55B 292B 22.53B 22.03B 930B P/E 2026 *
35.1x
P/E 2027 * 21.5x
Enterprise Value 8.32B 7.2B 6.81B 6.17B 11.57B 798B 11.66B 81.28B 31.27B 404B 31.24B 30.54B 1,290B EV / Sales 2026 *
2.64x
EV / Sales 2027 * 2.32x
Free-Float
44.36%
Yield 2026 *
-
Yield 2027 * -
1 day-3.46%
1 week-2.46%
Current month-4.81%
1 month-9.72%
3 months+2.40%
6 months+39.28%
Current year+31.98%
1 week 16.62
Extreme 16.615
17.36
1 month 16.62
Extreme 16.615
18.76
Current year 11.71
Extreme 11.71
19.26
1 year 9.49
Extreme 9.49
19.26
3 years 3.36
Extreme 3.36
19.26
5 years 1.24
Extreme 1.24
19.26
10 years 1.24
Extreme 1.24
24.48
Manager TitleAgeSince
Chief Executive Officer 59 2019-07-31
Chief Executive Officer 54 2019-07-31
Director of Finance/CFO 58 2023-11-06
Director TitleAgeSince
Director/Board Member 59 2023-11-06
Director/Board Member 70 2023-11-06
Director/Board Member 52 2023-11-06
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Don

Executive/Senior Manager

-80,000 0.0251%
8/21/26 Don

Executive/Senior Manager

-152,426 0.0477%
8/13/26 Sell

Director

-60,000 0.0188%
Change 5-day change 1-year change 3-year change Capi.($)
-3.46%-2.46%+69.87%+304.62% 6B
-0.34%+0.76%+51.36%+96.73% 1,015B
-0.08%-1.10%+50.04%+64.86% 642B
-0.06%+5.31%+20.40%+72.23% 463B
-0.22%+2.88%+38.48%+37.98% 353B
-0.07%+1.82%+16.57%+23.39% 265B
-0.31%+2.02%+6.15%+10.75% 254B
-1.55%-4.50%+36.84%+44.02% 206B
-1.60%-5.51%-22.30%-58.60% 191B
+0.20%-0.53%+29.61%+92.76% 182B
Average -0.82%-3.14%+29.70%+68.87% 357.62B
Weighted average by Cap. -0.38%-2.21%+34.20%+59.29%

Financials

2026 *2027 *
Net sales 3.15B 2.73B 2.58B 2.34B 4.39B 303B 4.42B 30.83B 11.86B 153B 11.85B 11.58B 489B 3.44B 2.98B 2.82B 2.55B 4.79B 330B 4.82B 33.61B 12.93B 167B 12.92B 12.63B 533B
Net income 165M 143M 135M 123M 230M 15.87B 232M 1.62B 622M 8.05B 621M 608M 25.66B 274M 237M 225M 203M 382M 26.3B 384M 2.68B 1.03B 13.34B 1.03B 1.01B 42.53B
Net Debt 2.32B 2.01B 1.9B 1.72B 3.23B 222B 3.25B 22.65B 8.72B 113B 8.71B 8.51B 360B 2B 1.73B 1.63B 1.48B 2.78B 191B 2.8B 19.5B 7.5B 97.05B 7.49B 7.33B 309B
Logo Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
Employees
8,700
Date Price Change Volume
26-09-15 US$16.63 -3.43% 813,382
26-09-14 US$17.22 +1.23% 1,596,898
26-09-11 US$17.01 +0.83% 1,157,718
26-09-10 US$16.87 -2.20% 1,036,034
26-09-09 US$17.25 +1.17% 1,472,382
Trader
Investor
Global
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
17.22USD
Average target price
21.33USD
Spread / Average Target
+23.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!